Kelly E. Carstens

Kelly E. Carstens

Auto-generated profile, based on publicly available information

Kelly E. Carstens

Office of Research and Development, Center for Computational Toxicology and Exposure, US Environmental Protection Agency, RTP, NC, USA

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 February 2023 in Chemical Research in Toxicology
Verified
Journal Article
Closed access
KCKelly E. Carstens
Kelly E. Carstens
TFTheresa Freudenrich
Theresa Freudenrich
KWKathleen Wallace
Kathleen Wallace
SCSeline Choo
Seline Choo
ACAmy Carpenter
Amy Carpenter
TSTimothy Shafer
Timothy Shafer

5 April 2024 in Toxics
Verified
Journal Article
Open access
PDF file
RJRichard Judson
Richard Judson
DSDoris Smith
Doris Smith
MDMichael J DeVito
Michael J DeVito
JWJohn Wambaugh
John Wambaugh
Barbara A WetmoreBarbara A Wetmore
Barbara A Wetmore
KCKelly E. Carstens
Kelly E. Carstens
Per- and polyfluoroalkyl substances (PFAS) are widely used, and their fluorinated state contributes to unique uses and stability but also long half-lives in the environment and humans. PFAS have been shown to be toxic, leading to immunosuppression, cancer, and other adverse health outcomes. Only a small fraction of the PFAS in commerce have been evaluated for toxicity using in vivo tests, which leads to a need to prioritize which compounds to examine further. Here, we demonstrate a prioritization approach that combines human biomonitoring data (blood concentrations) with bioactivity data (concentrations at which bioactivity is observed in vitro) for 31 PFAS. The in vitro data are taken from a battery of cell-based assays, mostly run on human cells. The result is a Bioactive Concentration to Blood Concentration Ratio (BCBCR), similar to a margin of exposure (MoE). Chemicals with low BCBCR values could then be prioritized for further risk assessment. Using this method, two of the PFAS, PFOA (Perfluorooctanoic Acid) and PFOS (Perfluorooctane Sulfonic Acid), have BCBCR values < 1 for some populations. An additional 9 PFAS have BCBCR values < 100 for some populations. This study shows a promising approach to screening level risk assessments of compounds such as PFAS that are long-lived in humans and other species.

23 May 2024 in Toxicology
Verified
Journal Article
Closed access
MMMelissa M. Martin
Melissa M. Martin
ACAmy F. Carpenter
Amy F. Carpenter
TSTimothy J. Shafer
Timothy J. Shafer
KFKatie Paul Friedman
Katie Paul Friedman
KCKelly E. Carstens
Kelly E. Carstens

6 July 2025 in Journal of Toxicology and Environmental Health, Part B
Verified
Journal Article
Closed access
GPGrace Patlewicz
Grace Patlewicz
RJRichard Judson
Richard Judson
KFKatie Paul Friedman
Katie Paul Friedman
Barbara A WetmoreBarbara A Wetmore
Barbara A Wetmore
MDMichael J DeVito
Michael J DeVito
RTRussell S. Thomas
Russell S. Thomas
Per- and polyfluoroalkyl substances (PFAS) comprise a large class of human-made chemicals that are in widespread use and present concerns for persistence, bioaccumulation and toxicity. Whilst a handful of PFAS have been characterized for their hazard profiles, the vast majority of PFAS have not been extensively studied. A comprehensive evaluation to characterize the hazard profiles of the thousands of available PFAS would require extensive resources in terms of cost, number of animals and time. An alternative and more efficient approach is to develop a structural chemical categorization approach to prioritize which PFAS or categories of PFAS should be subject to additional study. To that end, the U.S. Environmental Protection Agency (EPA), in collaboration with the National Institute of Environmental Health Sciences (NIEHS) Division of Translational Toxicology (DTT), initiated a research project in 2018 to screen approximately 150 PFAS through a battery of alternative model organisms, in vitro cell and biochemical assays, and in vitro toxico kinetic (TK) assays in order to inform chemical category and read-across approaches. The aim of this review summarizes the experimental testing undertaken, how data were processed, what insights were derived from a category perspective and how these might potentially inform subsequent tiered testing.

31 May 2025 in Computational Toxicology
Verified
Journal Article
Closed access
KCKelly E. Carstens
Kelly E. Carstens
ADArif Dönmez
Arif Dönmez
JHJui-Hua Hsieh
Jui-Hua Hsieh
KBKristina Bartmann
Kristina Bartmann
KFKatie Paul Friedman
Katie Paul Friedman
EFEllen Fritsche
Ellen Fritsche

26 June 2025 in NAM Journal
Verified
Journal Article
Open access
ZRZachary Rowson
Zachary Rowson
RSR. Woodrow Setzer
R. Woodrow Setzer
SPStephanie Padilla
Stephanie Padilla
KFKatie Paul Friedman
Katie Paul Friedman
KCKelly E. Carstens
Kelly E. Carstens
• The larval zebrafish locomotor response light/ dark assay has been identified as a new approach method for evaluating developmental neurotoxicity potential. • A lack of standardized data analysis techniques has limited cross-laboratory data comparisons and data integration. • Normalization using a Box-Cox transformation was implemented to address challenges such as inter-fish variability and non-normally distributed data. • Biphasic concentration-response modeling and bidirectional curve-fitting were informative for modeling zebrafish behavior. • Ten chemicals were identified as only active in the less commonly studied endpoints, suggesting the potential added value of a multi-endpoint suite for detecting complex behavioral profiles.